Skip Navigation LinksHome > March 2012 - Volume 26 - Issue 3 > Telmisartan as Metabolic Modulator: A New Perspective in Spo...
Journal of Strength & Conditioning Research:
doi: 10.1519/JSC.0b013e31824301b6
Original

Telmisartan as Metabolic Modulator: A New Perspective in Sports Doping?

Sanchis-Gomar, Fabian1; Lippi, Giuseppe2

Collapse Box

Abstract

Sanchis-Gomar, F and Lippi, G. Telmisartan as metabolic modulator: A new perspective in sports doping? J Strength Cond Res 26(3): 608–610, 2012—The World Antidoping Agency (WADA) has introduced some changes in the 2012 prohibited list. Among the leading innovations to the rules are that both 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (peroxisome proliferator–activated receptor-δ [PPAR-δ]-5' adenosine monophosphate-activated protein kinase [AMPK] agonist) and GW1516 (PPAR-δ-agonist) are no longer categorized as gene doping substances in the new 2012 prohibited list but as metabolic modulators in the class “Hormone and metabolic modulators.” This may also be valid for the angotensin II receptor blocker telmisartan. It has recently been shown that telmisartan might induce similar biochemical, biological, and metabolic changes (e.g., mitochondrial biogenesis and changes in skeletal muscle fiber type) as those reported for the former call of substances. We suspect that metabolic modulators abuse such as telmisartan might become a tangible threat in sports and should be thereby targeted as an important antidoping issue. The 2012 WADA prohibited list does not provide telmisartan for a potential doping drug, but arguments supporting the consideration to include them among “metabolic modulators” are at hand.

© 2012 National Strength and Conditioning Association

 

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.